Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

9.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pseudoleadership and the staying power of minoritized faculty.

Journal of the National Medical Association·2026
Same author

A c-Cbl/Cbl-b antagonist inhibits EGFR ubiquitylation and sustains EGFR phosphorylation to enhance corneal re-epithelialization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Knockout of c-Cbl and Cbl-b enhances corneal re-epithelialization in male, but not female, mice.

Experimental eye research·2025
Same author

Modulating Growth Factor Receptor Signaling to Promote Corneal Epithelial Homeostasis.

Cells·2023
Same author

Knockout of c-Cbl/Cbl-b slows c-Met trafficking resulting in enhanced signaling in corneal epithelial cells.

The Journal of biological chemistry·2023
Same author

Zeb1 facilitates corneal epithelial wound healing by maintaining corneal epithelial cell viability and mobility.

Communications biology·2023

Related Experiment Video

Updated: Mar 3, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K

EGFR-mediated apoptosis via STAT3.

Nicole M Jackson1, Brian P Ceresa1

  • 1Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, United States.

Experimental Cell Research
|April 24, 2017
PubMed
Summary
This summary is machine-generated.

Signal transducer and activator of transcription 3 (STAT3) mediates Epidermal Growth Factor Receptor (EGFR) signaling to induce apoptosis in MDA-MB-468 cells. This study identifies STAT3 as a key mediator in EGFR-induced programmed cell death.

Keywords:
A431 CellsApoptosisEpidermal Growth Factor ReceptorMDA-MB-468 CellsOncostatin MS3I-201STAT3Stattic

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

8.3K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 3, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K
Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

8.3K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The Epidermal Growth Factor Receptor (EGFR) plays a crucial role in cell growth and is implicated in both normal and malignant tissues.
  • Paradoxically, cancer cell lines overexpressing EGFR can undergo receptor-mediated apoptosis, a mechanism that remains poorly understood.
  • Understanding EGFR signaling in apoptosis is critical for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the underlying mechanism of Epidermal Growth Factor (EGF)-induced apoptosis in cancer cells.
  • To identify downstream effectors of EGFR signaling involved in apoptosis.
  • To investigate the role of Signal transducer and activator of transcription 3 (STAT3) in EGF-induced apoptosis.

Main Methods:

  • Assessed downstream effectors of EGFR in MDA-MB-468 cells under EGF stimulation.
  • Utilized alternative strategies to activate STAT3 independently of EGFR.
  • Reduced STAT3 expression using RNA interference (RNAi).
  • Measured Poly (ADP-ribose) polymerase (PARP) cleavage as an indicator of apoptosis.

Main Results:

  • STAT3 was identified as a potential mediator of EGF-induced apoptosis.
  • Independent activation of STAT3 induced apoptotic pathways.
  • RNAi-mediated reduction of STAT3 significantly attenuated EGF-induced PARP cleavage.
  • EGFR signaling in MDA-MB-468 cells promotes apoptosis via STAT3.

Conclusions:

  • STAT3 acts as a positive mediator in the process of EGF-induced apoptosis.
  • Targeting STAT3 may represent a therapeutic strategy for cancers with EGFR overexpression.
  • This research provides novel insights into the molecular mechanisms of EGFR-driven apoptosis.